Lowinger Timothy B

Avg. Two Year Performance

No purchase track record
(4%) Avg. Sale Return
(2%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return< 1%(2%)4%5%(4%)
Sale Success Rate2 of 132 of 132 of 132 of 130 of 13

Mersana Therapeutics, Inc.

Other » Other

SVP, Chief Sci.&Tech. Officer:

Holdings: 235.64K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--